# Study Assessing Pain Relief After Replacement of the Knee

> **NCT06799845** · PHASE2 · COMPLETED · sponsor: **Allay Therapeutics, Inc.** · enrollment: 226 (actual)

## Conditions studied

- Total Knee Arthroplasty (Postoperative Pain)

## Interventions

- **DRUG:** ATX101
- **DRUG:** bupivacaine hydrochloride
- **DRUG:** saline placebo

## Key facts

- **NCT ID:** NCT06799845
- **Lead sponsor:** Allay Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-03
- **Primary completion:** 2025-10-03
- **Final completion:** 2025-10-03
- **Target enrollment:** 226 (ACTUAL)
- **Last updated:** 2025-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06799845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06799845, "Study Assessing Pain Relief After Replacement of the Knee". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06799845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*